KRT20 and neuroendocrine carcinoma: We noticed that malignant cells of the intermediate state expressed neither the well-known DGC signature genes (MUC1, KRT20, PHGR1) nor the NEC signature genes (SCG3, CGA, CHGB), which was consistent with the aforementioned morphological and immune-histochemical staining findings.